Data Sharing in Pharmaceutical Supply Chains - Case European Medicines Verification System
dc.contributor | Aalto-yliopisto | fi |
dc.contributor | Aalto University | en |
dc.contributor.author | Levänen, Laura | en_US |
dc.contributor.author | Halminen, Olli | en_US |
dc.contributor.author | Tenhunen, Henni | en_US |
dc.contributor.author | Seppälä, Timo | en_US |
dc.contributor.department | Department of Industrial Engineering and Management | en |
dc.contributor.organization | Aalto University | en_US |
dc.date.accessioned | 2020-08-06T12:12:52Z | |
dc.date.available | 2020-08-06T12:12:52Z | |
dc.date.issued | 2020-06-26 | en_US |
dc.description.abstract | We study the perceived value derived from data sharing activities by the representatives of a Nordic pharmaceutical company in the introduction of the European Medicines Verification System (EMVS). The system is an end-to-end verification protocol that would potentially enable the pharmaceutical companies to access the sales-point data from within the system, while maintaining the control of their own data. The benefits of the system are most notably in developing data sharing with the wholesalers and end-customers. Development of data sharing practices might enable more transparent logistics, and more targeted services and products. | en |
dc.description.version | Peer reviewed | en |
dc.format.extent | 4 | |
dc.format.mimetype | application/pdf | en_US |
dc.identifier.citation | Levänen, L, Halminen, O, Tenhunen, H & Seppälä, T 2020, Data Sharing in Pharmaceutical Supply Chains - Case European Medicines Verification System. in The Importance of Health Informatics in Public Health during a Pandemic. Studies in Health Technology and Informatics, vol. 272, IOS Press, pp. 276-279. https://doi.org/10.3233/SHTI200548 | en |
dc.identifier.doi | 10.3233/SHTI200548 | en_US |
dc.identifier.isbn | 978-1-64368-092-7 | |
dc.identifier.isbn | 978-1-64368-093-4 | |
dc.identifier.issn | 0926-9630 | |
dc.identifier.other | PURE UUID: 33467889-6be6-4fde-b2b0-0bf5b7124ffc | en_US |
dc.identifier.other | PURE ITEMURL: https://research.aalto.fi/en/publications/33467889-6be6-4fde-b2b0-0bf5b7124ffc | en_US |
dc.identifier.other | PURE LINK: http://www.scopus.com/inward/record.url?scp=85087429280&partnerID=8YFLogxK | |
dc.identifier.other | PURE FILEURL: https://research.aalto.fi/files/44236041/Lev_nen_Data_Sharing.SHTI_272_SHTI200548.pdf | en_US |
dc.identifier.uri | https://aaltodoc.aalto.fi/handle/123456789/45499 | |
dc.identifier.urn | URN:NBN:fi:aalto-202008064458 | |
dc.language.iso | en | en |
dc.relation.ispartof | The Importance of Health Informatics in Public Health during a Pandemic | en |
dc.relation.ispartof | pp. 276-279 | en |
dc.relation.ispartofseries | Studies in Health Technology and Informatics ; Volume 272 | en |
dc.rights | openAccess | en |
dc.subject.keyword | Data Sharing | en_US |
dc.subject.keyword | European Medicines Verification System | en_US |
dc.subject.keyword | Pharmaceutical Industry | en_US |
dc.subject.keyword | Supply Chains | en_US |
dc.title | Data Sharing in Pharmaceutical Supply Chains - Case European Medicines Verification System | en |
dc.type | A3 Kirjan tai muun kokoomateoksen osa | fi |
dc.type.version | publishedVersion |